Compounds > fluorodopa f 18
Page last updated: 2024-08-24

fluorodopa f 18 and Pituitary Neoplasms

fluorodopa f 18 has been researched along with Pituitary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cuny, T; Ginet, M; Marie, PY; Schmitt, E; Verger, A1
Addeo, P; Bund, C; Goichot, B; Heimburger, C; Imperiale, A1

Other Studies

2 other study(ies) available for fluorodopa f 18 and Pituitary Neoplasms

ArticleYear
18F-FDOPA PET Imaging in Prolactinoma.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:8

    Topics: Dihydroxyphenylalanine; Humans; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography; Prolactinoma; Sensitivity and Specificity

2017
18F-FDOPA Uptake Reflects the Efficacy of Dopamine Agonists Treatment in Pituitary Prolactinoma.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:9

    Topics: Adult; Bone Neoplasms; Dihydroxyphenylalanine; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Prolactinoma; Radiopharmaceuticals

2018